Conferences

EACS 2021

The 18th European AIDS Conference (EACS 2021), organised by the European AIDS Clinical Society, was held in London, UK, and online from 27 to 30 October 2021. NAM aidsmap was the official scientific news reporter for the conference.
EACS 2021
Vaccinations & immunisations

People with HIV with CD4 counts below 200 show weaker responses to COVID-19 vaccines

Injectable & long-acting HIV treatment

Clinics will need new systems to administer injectable HIV therapies, says Canadian early adopter

Treatment for women

Women living with HIV are under-represented in research, limiting our understanding of co-morbid diseases

HIV testing programmes & uptake

HIV testing and prevention services affected badly by COVID in Europe, HIV treatment less so

PrEP programmes & uptake

For long-term PrEP, we need better definitions of adherence, conference hears

Vaccinations & immunisations

Most people with HIV accept COVID-19 vaccination; more safety information would help those who are hesitant

Elimination of hepatitis C

Europe far from achieving hepatitis C elimination targets

Coronavirus

Woman with HIV with low CD4 count remained positive on SARS-CoV-2 tests for over 5 months

Vaccinations & immunisations

Levels of COVID-19 vaccination in people with HIV in central and eastern Europe vary widely

Infant feeding

Half of Swiss mothers with HIV decide to breastfeed their baby when given the choice

Lung disease

Lung function declines faster in people living with HIV

Transgender people

Half of trans people attending English sexual health clinics took part in PrEP IMPACT study

Violence

People living with HIV should be routinely asked about domestic abuse

Side effects

Large international study finds 40% higher risk of serious cardiovascular problems in people taking abacavir since 2012

Resistance

New cases of multi-drug resistant HIV becoming rarer in Europe

PrEP programmes & uptake

First efficacy results from England's PrEP IMPACT Trial

HIV testing policies & guidelines

Half of speciality guidelines for medical conditions suggesting HIV don’t recommend HIV testing

Improving HIV care

Working together to improve HIV care in Europe

Interviews

EACS 2021: COVID-19 vaccinations

2 November 2021

A new study shows that people with HIV with CD4 counts below 200 produce weaker responses to COVID-19 vaccines than people with better immune function. Dr Andrea Antinori of the National Institute for Infectious Diseases, Italy, talks about the research presented to the EACS 2021 conference.

EACS 2021: Access to care in the pandemic

12 November 2021

Elena Vovc from the World Health Organization talks about the COVID-19 pandemic and how it has impacted HIV diagnoses, treatment and prevention. Elena presented these findings at a session at the EACS 2021 conference.

Conference bulletins

English

EACS 2021: Abacavir still causing serious cardiovascular problems, Friday 29 October 2021

(HTML)

EACS 2021: People with low CD4 counts have weaker response to COVID-19 vaccines, Monday 1 November 2021

(HTML)

EACS 2021: Clinics will need new systems to administer injectable HIV therapies, Friday 5 November 2021

(HTML)

French

EACS 2021: L'abacavir continue de causer des troubles cardiovasculaires graves, Vendredi 29 octobre 2021

(HTML)

EACS 2021: Les personnes ayant un faible taux de cellules CD4 ont une réponse immunitaire réduite aux vaccins COVID-19, Lundi 1er Novembre 2021

(HTML)

EACS 2021: Les cliniques auront besoin de nouveaux systèmes pour administrer les traitements injectables contre le VIH, Vendredi 5 novembre 2021

(HTML)

Spanish

EACS 2021: Abacavir sigue provocando graves problemas cardiovasculares, Viernes, 29 de octubre de 2021

(HTML)

EACS 2021: Las personas con recuentos bajos de CD4 presentan respuestas más débiles a las vacunas frente a la COVID-19, Lunes, 1 de noviembre de 2021

(HTML)

EACS 2021: Las clínicas precisarán nuevos protocolos para administrar los tratamientos antirretrovirales inyectables, Viernes, 5 de noviembre de 2021

(HTML)

Portuguese

EACS 2021: O abacavir ainda causa sérios problemas cardiovasculares, Sexta-feira, 29 de outubro de 2021

(HTML)

EACS 2021: As pessoas com contagens baixas de CD4 têm resposta mais fraca às vacinas COVID-19, Segunda-feira, 1 de novembro de 2021

(HTML)

EACS 2021: Clínicas precisarão de novos sistemas para administrar terapias injetáveis para o VIH, Sexta-feira, 5 de novembro de 2021

(HTML)

Russian

EACS 2021: Абакавир и серьезные сердечно-сосудистые осложнения, Пятница, 29 октября 2021 г.

(HTML)

EACS 2021: Лица с низким уровнем CD4-лимфоцитов имеют слабый иммунный ответ на вакцины COVID-19, Понедельник, 1 ноября 2021 г.

(HTML)

EACS 2021: Клиники нуждаются в переорганизации для проведения инъекционной ВИЧ-терапии, Пятница, 5 ноября 2021 г.

(HTML)

Italian

EACS 2021: L’abacavir provoca ancora gravi problemi cardiovascolari, Venerdì 29 ottobre 2021

(HTML)

EACS 2021: Più debole la risposta ai vaccini anti-COVID-19 se la conta dei CD4 è bassa, Lunedì 1 novembre 2021

(HTML)

EACS 2021: Serviranno nuovi sistemi per somministrare le terapie iniettabili, Venerdì 5 novembre 2021

(HTML)